Streetbeat News

Products Services

BBIO

BridgeBio announced results from its Phase 1/2 trial of the investigational gene therapy BBP-631 for Congenital Adrenal Hyperplasia. The trial showed increased cortisol production in higher dose cohorts, with mild to moderate adverse events. However, the results did not justify further capital investment, leading to a $50M budget reduction for gene therapy.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 8:49 pm

FTCI

FTC Solar, Inc. (NASDAQ:FTCI) shares surged in after-hours trading following a multi-year agreement with Strata Clean Energy to supply 500 megawatts of solar tracker technology, potentially expanding to over a gigawatt. The first project is expected to start in Q4 2024.

Portfolio Pulse from Erica Kollmann

September 10, 2024 | 8:48 pm

BBIO

BridgeBio Pharma announced that the FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its investigational gene therapy, BBP-812, for Canavan disease. This designation follows positive clinical data from the CANaspire Phase 1/2 trial.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 8:46 pm

GE

Deep-pocketed investors are showing significant interest in GE Aero options, with a mix of bullish and bearish sentiments. The options activity suggests a focus on a price range of $160 to $185. GE Aero's stock is currently trading at $166.98, with an anticipated earnings release in 42 days.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 8:46 pm

ENGN

enGene is on track to report preliminary data for its LEGEND study in September 2024. The company has $257.7 million in cash and equivalents, providing financial runway until 2027.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 8:36 pm

BNED

Barnes & Noble Education plans to spend around $20 million on capital expenditures in fiscal year 2025, primarily on store improvements and technology.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 8:33 pm

WOR

Worthington Enterprises, Inc. (NYSE:WOR) has initiated a modernization project at its Chilton, Wisconsin campus, which manufactures Bernzomatic and Mag-Torch hand torches and fuel cylinders. The project includes a new 58,000-square-foot building and equipment to enhance automation, production efficiency, and product quality.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 8:26 pm

INM

InMed Pharmaceuticals shares rose following the announcement of a new U.S. patent for their ocular drug delivery formulation, potentially enhancing their product offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 8:21 pm

MIRA

MIRA Pharmaceuticals' stock is rising following the announcement that it has chosen neuropathic pain as the primary indication for its new oral ketamine analog, Ketamir-2.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 8:20 pm

FTCI

FTC Solar's shares rise as the company is chosen by Strata Clean Energy to supply 500 megawatts of Voyager 2P solar tracker technology for U.S. projects, becoming the preferred supplier for three years.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 8:19 pm